Table 1

Reported GBS related to peripheral neuropathy for each checkpoint inhibitor

MedicationReported GBS (n)Units sold (2018–2022)
Avelumab8466 870
Ipilimumab59647 872
Atezolizumab42930 048
Nivolumab615 859 631
Pembrolizumab7210 154 878
  • GBS, Guillain-Barré syndrome.